EMA Taking Steps to Mitigate ‘Critical' Product Shortages Due to GMP Problems

Executive Summary The EMA is consulting on changes to the template for declaring non-compliance with good manufacturing practice, as the first step in a revision of the procedures for handling GMP-related shortages of “critical” medicines. Request a free trial today! Register for our free email digests:

Executive Summary

The EMA is consulting on changes to the template for declaring non-compliance with good manufacturing practice, as the first step in a revision of the procedures for handling GMP-related shortages of “critical” medicines.

Request a free trial today!

Register for our free email digests:

Compliance
Source: pink.pharmaintelligence.informa.com